ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

11,792Medicare Part D Prescriptions Filled, Including Refills
$579K Total Retail Price of All Prescriptions
468 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
POLYETHYLENE GLYCOL 3350 567 566
LEVOTHYROXINE SODIUM 551 537
WARFARIN SODIUM 469 458
SIMVASTATIN 422 413
METOPROLOL TARTRATE 413 410
OMEPRAZOLE 403 380
FUROSEMIDE 345 328
CITALOPRAM HBR 291 277
LISINOPRIL 287 279
LOSARTAN POTASSIUM 248 239
MIRTAZAPINE 208 205
ISOSORBIDE MONONITRATE ER 204 200
HYDROCHLOROTHIAZIDE 195 182
AMLODIPINE BESYLATE 188 173
POTASSIUM CHLORIDE 165 152
DIVALPROEX SODIUM 160 160
GABAPENTIN 147 145
METOPROLOL SUCCINATE 146 144
LANTUS 126 118
CHLORTHALIDONE 126 122
ATORVASTATIN CALCIUM 120 116
ADVAIR DISKUS 119 116
NAMENDA 116 116
METFORMIN HCL 112 99
TRAMADOL HCL 111 110
CLOPIDOGREL 106 106
PREDNISONE 89 69
CALCITRIOL 89 89
TAMSULOSIN HCL 89 78
TRIAMTERENE-HCTZ 84 82
DONEPEZIL HCL 83 83
RANITIDINE HCL 80 79
TORSEMIDE 77 77
LIDODERM 77 77
ALLOPURINOL 74 73
OXYCODONE HCL 73 68 S2
ATENOLOL 73 63
BUPROPION HCL SR 73 73
DIOVAN 71 71
NOVOLOG 71 69
ADACEL 70 70
FENTANYL 61 56 S2
TAMIFLU 60 58
FAMOTIDINE 60 60
SERTRALINE HCL 60 53
PLAVIX 60 60
ENALAPRIL MALEATE 57 56
TRIAMCINOLONE ACETONIDE 55 52
IPRATROPIUM BROMIDE 55 54
CEPHALEXIN 54 51
SPIRONOLACTONE 53 41
ALBUTEROL SULFATE 51 51
FLUOXETINE HCL 51 47
LOVASTATIN 51 51
TERAZOSIN HCL 50 50
DILTIAZEM 24HR ER 50 50
HYDRALAZINE HCL 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.